Check J H, Aly J
Clin Exp Obstet Gynecol. 2016;43(3):319-27.
To review the clinical importance of including the hypo-osmotic swelling (HOS) test in routine male fertility testing which in general is not evaluated by most physicians dealing with infertility.
Pregnancy rates were evaluated in patients with low HOS test scores. A low HOS test was specifically defined as having less than 50% of sperm exhibiting the normal physiologic response of tail swelling, when subjected to a hypo-osmolar solution. Pregnancy rates of patients with low HOS test were examined after intercourse, intrauterine insemination (IUI), conventional oocyte insemination, and in vitro fertilization (IVF). Patients with a low HOS test were also treated with a protein digestive enzyme chymotrypsin. Patients receiving intervention then underwent IUI, IVF with conventional oocyte insemination, or IVF with intracytoplasmic sperm injection (ICSI). Pregnancy rates of the cohort receiving intervention were then examined for comparison.
The HOS test abnormality leads to normal fertilization but almost invariably negatively effects embryo implantation. Treatment with chymotrypsin, or performing IVF with ICSI, can overcome the toxic protein causing the embryo implantation defect. This toxic protein may be cryolabile and freezing sperm or embryos may prove to be another mode of therapy.
The HOS abnormality may be the most reliable semen abnormality predicting failure to conceive even with IVF unless the defect is negated. Therapy is very effective. Unfortunately this test is rarely evaluated by most infertility specialists but it should be. The frequency increases with age.
回顾在常规男性生育力检测中纳入低渗肿胀(HOS)试验的临床重要性,而大多数处理不孕症的医生通常不会评估该试验。
对HOS试验评分低的患者的妊娠率进行评估。低HOS试验具体定义为,当精子置于低渗溶液中时,表现出尾部肿胀正常生理反应的精子少于50%。对HOS试验低的患者在性交、宫腔内人工授精(IUI)、常规卵母细胞授精和体外受精(IVF)后的妊娠率进行了检查。HOS试验低的患者还用蛋白消化酶胰凝乳蛋白酶进行了治疗。接受干预的患者随后接受了IUI、常规卵母细胞授精的IVF或卵胞浆内单精子注射(ICSI)的IVF。然后检查接受干预队列的妊娠率以作比较。
HOS试验异常导致正常受精,但几乎总是对胚胎着床产生负面影响。用胰凝乳蛋白酶治疗或进行ICSI的IVF可以克服导致胚胎着床缺陷的毒性蛋白。这种毒性蛋白可能对冷冻敏感,冷冻精子或胚胎可能被证明是另一种治疗方式。
HOS异常可能是预测即使进行IVF也无法受孕的最可靠的精液异常情况,除非该缺陷被消除。治疗非常有效。不幸的是,大多数不孕不育专家很少评估这项试验,但它应该被评估。其发生频率随年龄增加而升高。